Why the study?
Recurrence rates for VT remain high despite medications and invasive procedures, requiring novel alternatives like cardiac SBRT for refractory cases where arrhythmogenic areas are difficult to access conventionally.
Does cardiac SBRT with real-time motion tracking prevent VT recurrence in a patient with refractory ventricular tachycardia?
Does cardiac SBRT with real-time motion tracking prevent VT recurrence in a patient with refractory ventricular tachycardia?
Cardiac SBRT using advanced motion tracking and 3D reconstruction may be an effective non-invasive treatment option for patients with refractory ventricular tachycardia.
SBRT may reduce refractory VT burden; leaves open need for randomized trials before adoption.
Ventricular tachycardia (VT) is a potentially fatal arrhythmia that often requires a combination of medications and invasive procedures, including implantable cardioverter defibrillators (ICDs) and radiofrequency catheter ablation, to manage and treat. Despite these interventions, recurrence rates for VT remain high, particularly in patients with structural heart disease. Recent advancements in cardiac stereotactic body radiation therapy (SBRT) offer a promising alternative for patients with refractory VT, particularly for those whose arrhythmogenic areas are difficult to access through conventional methods. This study presents a novel approach to treating refractory VT, integrating advanced cardiorespiratory motion tracking using CyberKnife Synchrony (Accuray Incorporated, Madison, WI, USA) and a 3D heart reconstruction technology (inHeart, Pessac, France). The case involves a 66-year-old male with a history of dilated cardiomyopathy and recurrent VT, unresponsive to multiple medical and invasive interventions, including ICD implantation and catheter ablation. Using a combination of CT imaging, MRI, and electroanatomical mapping, we identified the arrhythmogenic region of the heart. He then underwent a single fraction of SBRT, 25 Gy to the target area, using real-time motion tracking via Synchrony. Six months post-treatment, the patient remained free from VT and has not required ICD therapies or further medical or procedural interventions. Our center has successfully implemented cardiac SBRT for refractory VT using inHeart technology for heart reconstruction and Synchrony for cardiorespiratory motion tracking.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: